<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="correction" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Oncol.</journal-id>
<journal-title>Frontiers in Oncology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Oncol.</abbrev-journal-title>
<issn pub-type="epub">2234-943X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fonc.2024.1395244</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Oncology</subject>
<subj-group>
<subject>Correction</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Corrigendum: miR-31-3p functions as a tumor suppressor by directly targeting GABBR2 in prostate cancer</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Choi</surname>
<given-names>Sujin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1777289"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Lee</surname>
<given-names>Soonchul</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1495331"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Han</surname>
<given-names>Young-Hoon</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Choi</surname>
<given-names>Junwon</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2241791"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Isaac</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lee</surname>
<given-names>Jusung</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>An</surname>
<given-names>Hyun-Ju</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1817784"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Orthopaedic Surgery, CHA Bundang Medical Center, CHA University School of Medicine</institution>, <addr-line>Pangyo-ro</addr-line>, <country>Republic of Korea</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Division of Radiation Cancer Research, Korea Institute of Radiological and Medical Sciences</institution>, <addr-line>Seoul</addr-line>, <country>Republic of Korea</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Molecular Science and Technology, Ajou University</institution>, <addr-line>Yeongtong-gu</addr-line>, <country>Republic of Korea</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department of General Surgery, CHA Bundang Medical Center, CHA University School of Medicine</institution>, <addr-line>Pangyo-ro</addr-line>, <country>Republic of Korea</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited and Reviewed by: Kirill Afonin, University of North Carolina at Charlotte, United States</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Hyun-Ju An, <email xlink:href="mailto:yks486ahj@naver.com">yks486ahj@naver.com</email>
</p>
</fn>
<fn fn-type="equal" id="fn003">
<p>&#x2020;These authors have contributed equally to this work</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>18</day>
<month>03</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>14</volume>
<elocation-id>1395244</elocation-id>
<history>
<date date-type="received">
<day>03</day>
<month>03</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>05</day>
<month>03</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Choi, Lee, Han, Choi, Kim, Lee and An</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Choi, Lee, Han, Choi, Kim, Lee and An</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="corrected-article" xlink:href="10.3389/fonc.2022.945057" ext-link-type="doi">A corrigendum on <article-title>miR-31-3p functions as a tumor suppressor by directly targeting GABBR2 in prostate cancer</article-title> by Choi S, Lee S, Han Y-H, Choi J, Kim I, Lee J and An H-J (2022) <italic>Front. Oncol.</italic> 12:945057. doi:&#xa0;<object-id>10.3389/fonc.2022.945057</object-id>
</related-article>
<kwd-group>
<kwd>miR-31-3p</kwd>
<kwd>GABBR2</kwd>
<kwd>prostate cancer</kwd>
<kwd>miRNA</kwd>
<kwd>tumor suppressor gene</kwd>
</kwd-group>
<counts>
<fig-count count="1"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="0"/>
<page-count count="2"/>
<word-count count="289"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Molecular and Cellular Oncology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>In the published article, there was a mistake in <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4</bold>
</xref> as published. The image of LNCap co-transfected with empty vector and control miRNA in Panel C was mistakenly mixed up with the image of the LNCap co-transfected with GABBR2 vector and miR-31-3p in Panel D. The corrected <xref ref-type="fig" rid="f4"><bold>Figure&#xa0;4</bold></xref> appears below.</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>miR-31-3p-induced tumor suppressive functions are associated with downregulation of GABBR2. <bold>(A)</bold> Restoration of GABBR2, p-ERK and p-JNK protein levels after ectopic expression of Myc-DDK-tagged-GABBR2. DU145, PC-3 and LNCap cells were transfected with a mixture of miR-31-3p (20 nM) and GABBR2 expression vector (4 &#x3bc;g). An unpaired two-tailed Student&#x2019;s t-test was used to calculate P values. Error bars represent mean &#xb1; SEM. *P value &lt; 0.05, **P value &lt; 0.01 and ***P value &lt; 0.001 vs. Cont (n = 3). <bold>(B)</bold> Ectopic expression of GABBR2 suppresses miR-31-3p-induced apoptosis of DU145, PC-3, and LNCap cells. An unpaired two-tailed Student&#x2019;s t-test was used to calculate P values. Error bars represent mean &#xb1; SEM. ***P value &lt; 0.001 vs. Cont (n = 3). <bold>(C, D)</bold> Ectopic expression of GABBR2 restores miR-31-3p-mediated inhibition of PC cell migration and invasion. An unpaired two-tailed Student&#x2019;s t-test was used to calculate P values. Error bars represent mean &#xb1; SEM. *P value &lt; 0.05, **P value &lt; 0.01 and ***P value &lt; 0.001 vs. Cont (n = 3).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fonc-14-1395244-g001.tif"/>
</fig>
<p>The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.</p>
</body>
<back>
<sec id="s1" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</back>
</article>